---
id: benchling
name: Benchling (CRISPR Tools)
aka: []
category: Guide RNA Design
secondary_categories: [Workflow Automation, Visualization, Sequence Management]
description: "Benchling is a commercial cloud R&D platform whose molecular biology suite includes a CRISPR guide design module that finds and scores guides directly against sequences stored in the user's registry. Its value is integration: guides live next to plasmid maps, primers, sequencing data, and lab notebook entries, with team collaboration and versioning. It is widely used in industry and increasingly in academic labs with institutional access."
supported_editors: [Cas9, Cas12a, Base editing (CBE), Base editing (ABE)]
installation: "No install; hosted SaaS with free academic and paid tiers."
web_interface: { available: true, url: "https://www.benchling.com", login_required: true }
license: "Proprietary"
platform: [Cloud, Web, API]
maintenance_status: Active
superseded_by: null
publication:
  title: null
  venue: null
  year: null
  doi: null
  url: null
citations: { count: null, source: "n/a", as_of: null, note: "Not a paper-based tool; measured by adoption rather than citations." }
github: { available: false, url: null, stars: null, last_commit: null }
documentation: "https://docs.benchling.com"
strengths:
  - "Guides live in the same environment as sequences, plasmids, primers, and notebook, which cuts context switching."
  - "Strong collaboration, permissions, versioning, and audit trail for teams."
  - "No installation and a usable interface for bench scientists."
  - "API for programmatic access and pipeline integration."
weaknesses:
  - "Proprietary and account-gated; not reproducible or inspectable the way open tools are."
  - "Scoring methods are less transparent than open aggregators like CRISPOR."
  - "Full value depends on adopting the wider platform."
ideal_use_cases:
  - "Teams already managing constructs and sequencing in Benchling who want design in the same place."
  - "Industry settings needing audit trails and collaboration around editing projects."
limitations:
  - "Not suitable where open, citable, reproducible methods are required."
  - "Advanced base and prime editing design is less specialized than dedicated academic tools."
competing_tools: [crispor, chopchop]
related_tools: [crispresso2]
screenshots: []
notable_publications_using: []
last_known_update: null
state_of_the_art:
  is_sota: true
  rationale: "Leading commercial integrated design and data management option; open tools preferred for transparent citable scoring. For transparent, open, citable guide scoring specifically, open academic tools remain preferred."
  as_of: "2026-07-03"
tags: [commercial, cloud, gui, molecular-biology-suite, collaboration, no-install]
ai_enabled: false
verified_on: "2026-07-03"
verification_notes: "Confirm current academic vs paid tier structure and the exact list of supported editor design modules at build time, since commercial features change frequently. No citation metric applies."
---

# Benchling (CRISPR Tools)

> Guide design inside a broader commercial cloud platform for life sciences R&D.

## Example workflow

1. Import or open a sequence in the Benchling registry.
2. Run the CRISPR guide design tool against it and review scored candidates on the sequence map.
3. Save chosen guides as linked entities and order primers or oligos.
4. Attach downstream sequencing results to the same record.

## Notes

No single primary methods paper; the guide scoring draws on published algorithms (for example on-target and off-target scores from the literature) — cite the platform and the underlying score references as appropriate. Product screenshots are on benchling.com and in Benchling documentation (check usage terms before rehosting). Cited in methods sections as the design and sequence management environment across many industry-linked studies; usually referenced as software rather than a primary method. Geneious is a comparable commercial suite but does not yet have its own profile here.
